CRDO: Credo Initiated
Credo Technology Group Holding Ltd initiated with Outperform rating and $325 price target by Evercore ISI Group analyst Mark Lipacis
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. HC Wainwright & Co. analyst Swayampakula Ramakanth initiated coverage on Conexeu Sciences Inc (NASDAQ: CNXU ) with a Buy rating and announced a price target of $20.
Conexeu Sciences shares closed at $13.28 on Thursday. See how other analysts view this stock. Evercore ISI Group analyst Mark Lipacis initiated coverage on Credo Technology Group Holding Ltd (NASDAQ: CRDO ) with an Outperform rating and announced a price target of $325. Credo Technology shares closed at $271.83 on Thursday.
See how other analysts view this stock. HC Wainwright & Co. analyst Patrick R. Trucchio initiated coverage on Agomab Therapeutics NV (NASDAQ: AGMB ) with a Buy rating and announced a price target of $35.
AgomAb Therapeutics shares closed at $10.98 on Thursday. See how other analysts view this stock. Keybanc analyst Michael Leshock initiated coverage on Space Exploration Technologies Corp (NASDAQ: SPCX ) with a Sector Weight rating. SpaceX shares closed at $185.00 on Thursday.
See how other analysts view this stock. HC Wainwright & Co. analyst Patrick R. Trucchio initiated coverage on Faeth Therapeutics, Inc.
(NASDAQ: FTH ) with a Buy rating and announced a price target of $60. Faeth Therapeutics shares closed at $17.82 on Thursday. See how other analysts view this stock. Considering buying CRDO stock?
Here’s what analysts think: Photo via Shutterstock